Finance

Lists
Why is DRTS down ၁၀.၅၄%?
Dive Deeper
DRTS:NASDAQ
Alpha Tau Medical Ltd
၁၁.၉၇ US$
-၁၀.၅၄%
(-၁.၄၁) 1D
၁၁.၉၇ US$
၀.၀၀% (၀.၀၀)
Pre-market
Closed: နို ၁၆, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRTS...
Open
၁၄.၂၀ US$
High
၁၄.၄၁ US$
Low
၁၁.၈၀ US$
Mkt. cap
၁၁၃.၄၉ ဋေ
Avg. vol.
၅.၀၄ သိန်း
Volume
၇၅၁.၀၀
52-wk high
၁၅.၇၉ US$
52-wk low
၃.၄၃ US$
Beta
၁.၂၈
Shares outstanding
၉.၂၃ ကုဋေ
No. of employees
၁၂၁
Open
၁၄.၂၀ US$
High
၁၄.၄၁ US$
Low
၁၁.၈၀ US$
Mkt. cap
၁၁၃.၄၉ ဋေ
Avg. vol.
၅.၀၄ သိန်း
Volume
၇၅၁.၀၀
52-wk high
၁၅.၇၉ US$
52-wk low
၃.၄၃ US$
Beta
၁.၂၈
Shares outstanding
၉.၂၃ ကုဋေ
No. of employees
၁၂၁
News stories
From web sources and news partners
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၁၉ နာရီ
Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Why is Alpha Tau Medical stock surging today?
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၂၁ နာရီ
12 Health Care Stocks Moving In Monday's Pre-Market Session
About Alpha Tau Medical Ltd
CEO-
Employees၁၂၁
Founded၂၀၁၅
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to DRTS in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DRTS in the last 3 months.
Highest
Current ၁၁.၉၇ US$
၁၇.၀၀ US$ (+၄၂.၀၂%)
Average
၁၃.၆၇ US$ (+၁၄.၂၀%)
Lowest
၈.၀၀ US$ (-၃၃.၁၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
၁၆.၀၀ US$
+၃၃.၇%
08/12/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
၈.၀၀ US$
-၃၃.၂%
08/11/2026
Lukas Shumway
Barclays
Buy
Maintained
၁၇.၀၀ US$
+၄၂%
08/11/2026
Unknown Analyst
Barclays
Buy
Initiated
၁၅.၀၀ US$
+၂၅.၃%
05/28/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
၁၄.၀၀ US$
+၁၇%
05/12/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
၉.၀၀ US$
-၂၄.၈%
03/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၈.၃၁ သန်း
၉.၅၈ သန်း
၁.၁၀ ကုဋေ
၉.၉၁ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၄၂ သန်း
၃.၀၃ သန်း
၂.၃၄ သန်း
၃.၈၈ သန်း
Operating expense
၁.၀၇ ကုဋေ
၁.၂၆ ကုဋေ
၁.၃၃ ကုဋေ
၁.၃၈ ကုဋေ
Total operating expenses
၁.၀၇ ကုဋေ
၁.၂၆ ကုဋေ
၁.၃၃ ကုဋေ
၁.၃၈ ကုဋေ
Operating income
-၁.၀၇ ကုဋေ
-၁.၂၆ ကုဋေ
-၁.၃၃ ကုဋေ
-၁.၃၈ ကုဋေ
Other non operating income
၄.၇၅ သိန်း
-၂.၀၉ သန်း
-
-၄.၂၂ ကုဋေ
EBT including unusual items
-၁.၁၇ ကုဋေ
-၁.၂၂ ကုဋေ
-၂.၃၀ ကုဋေ
-၄.၅၆ ကုဋေ
EBT excluding unusual items
-၁.၁၇ ကုဋေ
-၁.၂၂ ကုဋေ
-၂.၃၀ ကုဋေ
-၄.၅၆ ကုဋေ
Income tax expense
-၈.၀၀ ထောင်
-၃.၅၀ သောင်း
-၁.၁၀ သောင်း
၂.၂၉ သိန်း
Effective tax rate
၀.၀၇%
၀.၂၉%
၀.၀၅%
-၀.၅၀%
Other operating expenses
-
-
-
-
Net income
-၁.၁၇ ကုဋေ
-၁.၂၁ ကုဋေ
-၂.၂၉ ကုဋေ
-၄.၅၈ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၄
-၀.၁၄
-၀.၂၆
-၀.၅၀
Interest and investment income
-
၄.၁၄ သန်း
-
၁.၁၄ ကုဋေ
Interest expense
-၂.၃၄ သန်း
-
-၉.၆၄ သန်း
-
Net interest expenses
-၂.၃၄ သန်း
၄.၁၄ သန်း
-၉.၆၄ သန်း
၁.၁၄ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၅ ကုဋေ
-၁.၂၃ ကုဋေ
-၁.၃၀ ကုဋေ
-၁.၃၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ